Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

2. april 2021 oppdatert av: Children's Oncology Group

High Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)

This randomized phase III trial is studying dexamethasone to see how well it works compared to prednisone during induction therapy. This trial is also studying methotrexate and leucovorin calcium to see how well they work compared to methotrexate alone during maintenance therapy in treating patients with newly diagnosed acute lymphoblastic leukemia (ALL). Drugs used in chemotherapy, such as dexamethasone, prednisone, methotrexate, and leucovorin calcium, work in different ways to stop cancer cells from dividing so they stop growing or die. Giving more than one drug may kill more cancer cells. It is not yet known which combination chemotherapy regimen is more effective in treating acute lymphoblastic leukemia.

Studieoversikt

Detaljert beskrivelse

OBJECTIVES:

I. Improve the outcome of children with high-risk acute lymphoblastic leukemia treated with 2 different chemotherapy regimens.

II. Determine the relative safety and efficacy of dexamethasone given for 14 days vs prednisone given for 28 days during induction.

III. Determine the relative safety and efficacy of high-dose methotrexate (5gm/m^2) with leucovorin rescue compared to escalating methotrexate without leucovorin rescue (Capizzi I) during interim maintenance I.

IV. Correlate Day 29 minimal residual disease (MRD) with event-free survival (EFS) and overall survival (OS).

V. Correlate early marrow response status with day-29 MRD status. VI. Improve outcome by identifying additional high risk patients by Day 29 MRD for treatment with fully augmented Berlin-Frankfurt-Munster (BFM).

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to early response (slow early response [SER] vs rapid early response [RER]). Induction therapy: Patients are randomized to 1 of 4 treatment arms.

ARM I: Patients receive cytarabine intrathecally (IT) on day 1, vincristine intravenously (IV) and daunorubicin IV on days 1, 8, 15, and 22, dexamethasone orally (PO) or IV twice daily (BID) on days 1-14, methotrexate (MTX) IT on days 8 and 29* and pegaspargase intramuscularly (IM) once on day 4, 5, or 6.

NOTE: *Patients with CNS3 disease (WBC > 5/mL in cerebrospinal fluid and positive for blasts on cytospin) also receive MTX IT on days 15 and 22.

ARM II: Patients receive induction therapy as in Arm I.

ARM III: Patients receive cytarabine, vincristine, daunorubicin, and pegaspargase as in Arm I. Patients also receive prednisone PO or IV BID on days 1-28 and MTX IT on days 8 and 29.

ARM IV: Patients receive induction therapy as in Arm III.

Patients in all arms are evaluated at day 29 of induction therapy. Patients with M3 disease are removed from study. Patients with M1 disease and less than 1% minimal residual disease (MRD) proceed to consolidation therapy beginning on day 36. Patients with M2 disease OR with MI disease and at least 1% MRD receive extended induction therapy for 2 additional weeks. Patients with SER disease and MLL rearrangements are removed from the study but may be eligible for treatment on protocol COG-AALL0031.

Extended induction therapy: Patients continue to receive therapy on the arm to which they were originally randomized.

ARMS I and II: Patients receive dexamethasone PO or IV BID on days 1-14, vincristine IV on days 1 and 8, daunorubicin IV on day 1 and pegaspargase IM on day 4, 5, or 6 and are then reevaluated.

ARMS III and IV: Patients receive prednisone PO or IV BID on days 1-14, and vincristine, daunorubicin, and pegaspargase as in Arms I and II and are then reevaluated.

Patients on all arms who have M1 disease and less than 1% MRD after extended induction proceed to consolidation therapy and continue as SER patients. All other patients are removed from study.

Consolidation therapy: All patients receive cyclophosphamide IV over 30 minutes on days 1 and 29, cytarabine IV or subcutaneously (SC) on days 1-4, 8-11, 29-32, and 36-39, mercaptopurine (MP) PO on days 1-14 and 29-42, vincristine IV on days 15, 22, 43, and 50; pegaspargase IM on days 15 and 43 and MTX* IT on days 1, 8, 15, and 22. Patients with testicular disease also receive radiotherapy to the testes.

NOTE: *Patients with CNS3 disease receive MTX on days 1 and 8 only.

Interim maintenance therapy I: Patients continue to receive treatment on the arm to which they were originally randomized.

ARM I: (escalating-dose MTX) Patients receive vincristine IV and escalating-dose MTX IV on days 1, 11, 21, 31, and 41, pegaspargase IM on days 2 and 22 and MTX IT on days 1 and 21.

ARM II: (high-dose MTX) Patients receive vincristine IV and high-dose methotrexate IV over 24 hours on days 1, 15, 29, and 43, MP PO on days 1-56 and IT MTX on days 1 and 29. Patients also receive leucovorin calcium IV every 6 hours for at least 3 doses, beginning 42 hours after start of each MTX infusion.

ARM III: (escalating-dose MTX) Patients receive interim maintenance I therapy as in Arm I.

ARM IV: (high-dose MTX) Patients receive interim maintenance I therapy as in Arm II.

DELAYED INTENSIFICATION THERAPY I: All patients receive vincristine IV on days 1, 8, 15, 43, and 50, dexamethasone PO or IV BID on days 1 to 21 for patients age 1 to 12 OR on days 1-7 and 15-21 for patients age 13 and over, doxorubicin IV on days 1, 8, and 15, pegaspargase IM on day 4, 5, or 6 AND day 43, cyclophosphamide IV over 30 minutes on day 29, cytarabine IV or SC on days 30-33 and 37-40, thioguanine PO on days 29-42 and MTX IT on days 1, 29, and 36.After delayed intensification I, SER patients proceed to interim maintenance II and delayed intensification II. RER patients proceed directly to maintenance.

INTERIM MAINTENANCE THERAPY II: All patients receive vincristine IV and MTX IV on days 1, 11, 21, 31, and 41, pegaspargase IM on days 2 and 22; and MTX IT on days 1 and 21. Patients then proceed to delayed intensification II.

DELAYED INTENSIFICATION THERAPY II: All patients receive therapy as in delayed intensification I, arm I. CNS3 patients also receive radiotherapy for 3-10 days, beginning on day 29. All other SER patients, patients with MLL rearrangements, and some patients pretreated with steroids (> 48 hours within the week prior to diagnosis) receive prophylactic cranial radiotherapy (CRT) for 8 days, beginning on day 29. Patients then proceed to maintenance therapy.

MAINTENANCE THERAPY: All patients receive vincristine IV on days 1, 29, and 57, dexamethasone PO BID on days 1-5, 29-33, and 57-61, MP PO on days 1-84, MTX IT on day 1*; and MTX PO on days 1, 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, and 78.

NOTE: *RER (who did not undergo CRT) patients also receive MTX IT on day 29 for maintenance courses 1-4.

In all arms, maintenance therapy repeats every 12 weeks until total duration of therapy is 2 years from the start of interim maintenance I for female patients and 3 years from the start of interim maintenance I for male patients. Patients with testicular disease may receive testicular radiotherapy for 8 days during one of the first 3 courses of maintenance therapy. Patients are followed monthly for 1 year, every 2 months for 1 year, every 3 months for 1 year, every 6 months for 1 year, and then annually thereafter.

Studietype

Intervensjonell

Registrering (Faktiske)

3154

Fase

  • Fase 3

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Queensland
      • Herston, Queensland, Australia, 4029
        • Royal Brisbane and Women's Hospital
      • Herston, Queensland, Australia, 4029
        • Royal Children's Hospital-Brisbane
    • South Australia
      • North Adelaide, South Australia, Australia, 5006
        • Women's and Children's Hospital-Adelaide
    • Victoria
      • Parkville, Victoria, Australia, 3052
        • Royal Children's Hospital
    • Western Australia
      • Perth, Western Australia, Australia, 6008
        • Princess Margaret Hospital for Children
    • Alberta
      • Calgary, Alberta, Canada, T3B 6A8
        • Alberta Children's Hospital
      • Edmonton, Alberta, Canada, T6G 2B7
        • University of Alberta Hospital
    • British Columbia
      • Vancouver, British Columbia, Canada, V6H 3V4
        • British Columbia Children's Hospital
    • Manitoba
      • Winnipeg, Manitoba, Canada, R3E 0V9
        • CancerCare Manitoba
    • Newfoundland and Labrador
      • Saint John's, Newfoundland and Labrador, Canada, A1B 3V6
        • Janeway Child Health Centre
    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3K 6R8
        • IWK Health Centre
    • Ontario
      • Kingston, Ontario, Canada, K7L 2V7
        • Kingston Health Sciences Centre
      • London, Ontario, Canada, N6A 5W9
        • Children's Hospital
      • London, Ontario, Canada, N6K 1C2
        • Victoria Hospital
      • Ottawa, Ontario, Canada, K1H 8L1
        • Children's Hospital of Eastern Ontario
      • Toronto, Ontario, Canada, M5G 1X8
        • Hospital for Sick Children
    • Quebec
      • Montreal, Quebec, Canada, H3H 1P3
        • The Montreal Children's Hospital of the MUHC
      • Sherbrooke, Quebec, Canada, J1H 5N4
        • Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
    • Saskatchewan
      • Regina, Saskatchewan, Canada, S4T 7T1
        • Allan Blair Cancer Centre
      • Saskatoon, Saskatchewan, Canada, S7N 4H4
        • Saskatoon Cancer Centre
    • Alabama
      • Birmingham, Alabama, Forente stater, 35233
        • University of Alabama at Birmingham Cancer Center
      • Birmingham, Alabama, Forente stater, 35233
        • Children's Hospital of Alabama
      • Mobile, Alabama, Forente stater, 36604
        • USA Health Strada Patient Care Center
    • Arizona
      • Mesa, Arizona, Forente stater, 85202
        • Banner Children's at Desert
      • Phoenix, Arizona, Forente stater, 85016
        • Phoenix Childrens Hospital
      • Tucson, Arizona, Forente stater, 85719
        • Banner University Medical Center - Tucson
    • Arkansas
      • Little Rock, Arkansas, Forente stater, 72205
        • University of Arkansas for Medical Sciences
      • Little Rock, Arkansas, Forente stater, 72202-3591
        • Arkansas Children's Hospital
    • California
      • Downey, California, Forente stater, 90242
        • Kaiser Permanente Downey Medical Center
      • Duarte, California, Forente stater, 91010
        • City of Hope Comprehensive Cancer Center
      • Loma Linda, California, Forente stater, 92354
        • Loma Linda University Medical Center
      • Long Beach, California, Forente stater, 90806
        • Miller Children's and Women's Hospital Long Beach
      • Los Angeles, California, Forente stater, 90027
        • Children's Hospital Los Angeles
      • Los Angeles, California, Forente stater, 90095
        • UCLA / Jonsson Comprehensive Cancer Center
      • Los Angeles, California, Forente stater, 90048
        • Cedars Sinai Medical Center
      • Los Angeles, California, Forente stater, 90095
        • Mattel Children's Hospital UCLA
      • Madera, California, Forente stater, 93636
        • Valley Children's Hospital
      • Oakland, California, Forente stater, 94609
        • UCSF Benioff Children's Hospital Oakland
      • Oakland, California, Forente stater, 94611
        • Kaiser Permanente-Oakland
      • Orange, California, Forente stater, 92868
        • Children's Hospital of Orange County
      • Palo Alto, California, Forente stater, 94304
        • Lucile Packard Children's Hospital Stanford University
      • Sacramento, California, Forente stater, 95816
        • Sutter Medical Center Sacramento
      • Sacramento, California, Forente stater, 95817
        • University of California Davis Comprehensive Cancer Center
      • San Diego, California, Forente stater, 92123
        • Rady Children's Hospital - San Diego
      • San Francisco, California, Forente stater, 94143
        • UCSF Medical Center-Parnassus
      • Santa Barbara, California, Forente stater, 93102
        • Santa Barbara Cottage Hospital
    • Colorado
      • Aurora, Colorado, Forente stater, 80045
        • Children's Hospital Colorado
      • Denver, Colorado, Forente stater, 80218
        • Presbyterian - Saint Lukes Medical Center - Health One
      • Denver, Colorado, Forente stater, 80218
        • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
    • Connecticut
      • Farmington, Connecticut, Forente stater, 06030
        • University of Connecticut
      • Hartford, Connecticut, Forente stater, 06106
        • Connecticut Children's Medical Center
      • New Haven, Connecticut, Forente stater, 06520
        • Yale University
    • Delaware
      • Wilmington, Delaware, Forente stater, 19803
        • Alfred I duPont Hospital for Children
    • District of Columbia
      • Washington, District of Columbia, Forente stater, 20010
        • Children's National Medical Center
      • Washington, District of Columbia, Forente stater, 20007
        • MedStar Georgetown University Hospital
    • Florida
      • Fort Lauderdale, Florida, Forente stater, 33316
        • Broward Health Medical Center
      • Fort Myers, Florida, Forente stater, 33908
        • Golisano Children's Hospital of Southwest Florida
      • Fort Myers, Florida, Forente stater, 33901
        • Lee Memorial Health System
      • Gainesville, Florida, Forente stater, 32610
        • University of Florida Health Science Center - Gainesville
      • Hollywood, Florida, Forente stater, 33021
        • Memorial Regional Hospital/Joe DiMaggio Children's Hospital
      • Jacksonville, Florida, Forente stater, 32207
        • Nemours Children's Clinic-Jacksonville
      • Miami, Florida, Forente stater, 33155
        • Nicklaus Children's Hospital
      • Miami, Florida, Forente stater, 33136
        • University of Miami Miller School of Medicine-Sylvester Cancer Center
      • Miami, Florida, Forente stater, 33176
        • Miami Cancer Institute
      • Orlando, Florida, Forente stater, 32806
        • Orlando Health Cancer Institute
      • Orlando, Florida, Forente stater, 32806
        • Nemours Children's Clinic - Orlando
      • Orlando, Florida, Forente stater, 32827
        • Nemours Children's Hospital
      • Orlando, Florida, Forente stater, 32803
        • AdventHealth Orlando
      • Pensacola, Florida, Forente stater, 32504
        • Sacred Heart Hospital
      • Pensacola, Florida, Forente stater, 32504
        • Nemours Children's Clinic - Pensacola
      • Saint Petersburg, Florida, Forente stater, 33701
        • Johns Hopkins All Children's Hospital
      • Tampa, Florida, Forente stater, 33607
        • Saint Joseph's Hospital/Children's Hospital-Tampa
      • West Palm Beach, Florida, Forente stater, 33407
        • Saint Mary's Hospital
    • Georgia
      • Atlanta, Georgia, Forente stater, 30322
        • Emory University Hospital/Winship Cancer Institute
      • Atlanta, Georgia, Forente stater, 30322
        • Children's Healthcare of Atlanta - Egleston
      • Augusta, Georgia, Forente stater, 30912
        • Augusta University Medical Center
      • Savannah, Georgia, Forente stater, 31404
        • Memorial Health University Medical Center
    • Hawaii
      • Honolulu, Hawaii, Forente stater, 96813
        • University of Hawaii Cancer Center
      • Honolulu, Hawaii, Forente stater, 96859
        • Tripler Army Medical Center
    • Idaho
      • Boise, Idaho, Forente stater, 83712
        • Saint Luke's Cancer Institute - Boise
    • Illinois
      • Chicago, Illinois, Forente stater, 60612
        • Rush University Medical Center
      • Chicago, Illinois, Forente stater, 60637
        • University of Chicago Comprehensive Cancer Center
      • Chicago, Illinois, Forente stater, 60612
        • University of Illinois
      • Chicago, Illinois, Forente stater, 60611
        • Lurie Children's Hospital-Chicago
      • Maywood, Illinois, Forente stater, 60153
        • Loyola University Medical Center
      • Oak Lawn, Illinois, Forente stater, 60453
        • Advocate Children's Hospital-Oak Lawn
      • Park Ridge, Illinois, Forente stater, 60068
        • Advocate Lutheran General Hospital
      • Springfield, Illinois, Forente stater, 62702
        • Southern Illinois University School of Medicine
    • Indiana
      • Indianapolis, Indiana, Forente stater, 46202
        • Indiana University/Melvin and Bren Simon Cancer Center
      • Indianapolis, Indiana, Forente stater, 46202
        • Riley Hospital for Children
      • Indianapolis, Indiana, Forente stater, 46260
        • Saint Vincent Hospital and Health Care Center
    • Iowa
      • Des Moines, Iowa, Forente stater, 50309
        • Blank Children's Hospital
      • Iowa City, Iowa, Forente stater, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
    • Kansas
      • Kansas City, Kansas, Forente stater, 66160
        • University of Kansas Cancer Center
    • Kentucky
      • Lexington, Kentucky, Forente stater, 40536
        • University of Kentucky/Markey Cancer Center
      • Louisville, Kentucky, Forente stater, 40202
        • Norton Children's Hospital
    • Louisiana
      • New Orleans, Louisiana, Forente stater, 70112
        • Tulane University Health Sciences Center
      • New Orleans, Louisiana, Forente stater, 70118
        • Children's Hospital New Orleans
    • Maine
      • Bangor, Maine, Forente stater, 04401
        • Eastern Maine Medical Center
      • Scarborough, Maine, Forente stater, 04074
        • Maine Children's Cancer Program
    • Maryland
      • Baltimore, Maryland, Forente stater, 21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
      • Baltimore, Maryland, Forente stater, 21215
        • Sinai Hospital of Baltimore
      • Baltimore, Maryland, Forente stater, 21201
        • University of Maryland/Greenebaum Cancer Center
      • Bethesda, Maryland, Forente stater, 20889-5600
        • Walter Reed National Military Medical Center
    • Massachusetts
      • Boston, Massachusetts, Forente stater, 02114
        • Massachusetts General Hospital Cancer Center
      • Boston, Massachusetts, Forente stater, 02111
        • Tufts Children's Hospital
      • Springfield, Massachusetts, Forente stater, 01199
        • Baystate Medical Center
      • Worcester, Massachusetts, Forente stater, 01655
        • UMass Memorial Medical Center - University Campus
    • Michigan
      • Ann Arbor, Michigan, Forente stater, 48109
        • C S Mott Children's Hospital
      • Detroit, Michigan, Forente stater, 48201
        • Wayne State University/Karmanos Cancer Institute
      • Detroit, Michigan, Forente stater, 48236
        • Ascension Saint John Hospital
      • East Lansing, Michigan, Forente stater, 48824-7016
        • Michigan State University Clinical Center
      • Flint, Michigan, Forente stater, 48503
        • Hurley Medical Center
      • Grand Rapids, Michigan, Forente stater, 49503
        • Spectrum Health at Butterworth Campus
      • Grand Rapids, Michigan, Forente stater, 49503
        • Helen DeVos Children's Hospital at Spectrum Health
      • Kalamazoo, Michigan, Forente stater, 49007
        • Bronson Methodist Hospital
      • Kalamazoo, Michigan, Forente stater, 49008
        • Kalamazoo Center for Medical Studies
      • Royal Oak, Michigan, Forente stater, 48073
        • William Beaumont Hospital-Royal Oak
      • Royal Oak, Michigan, Forente stater, 48073
        • Beaumont Children's Hospital-Royal Oak
    • Minnesota
      • Minneapolis, Minnesota, Forente stater, 55404
        • Children's Hospitals and Clinics of Minnesota - Minneapolis
      • Minneapolis, Minnesota, Forente stater, 55455
        • University of Minnesota/Masonic Cancer Center
      • Rochester, Minnesota, Forente stater, 55905
        • Mayo Clinic in Rochester
      • Saint Paul, Minnesota, Forente stater, 55102
        • Children's Hospital and Clinic-Saint Paul
    • Mississippi
      • Jackson, Mississippi, Forente stater, 39216
        • University of Mississippi Medical Center
    • Missouri
      • Columbia, Missouri, Forente stater, 65201
        • Columbia Regional
      • Columbia, Missouri, Forente stater, 65212
        • University of Missouri - Ellis Fischel
      • Kansas City, Missouri, Forente stater, 64108
        • Children's Mercy Hospitals and Clinics
      • Saint Louis, Missouri, Forente stater, 63110
        • Washington University School of Medicine
      • Saint Louis, Missouri, Forente stater, 63104
        • Cardinal Glennon Children's Medical Center
    • Nebraska
      • Omaha, Nebraska, Forente stater, 68198
        • University of Nebraska Medical Center
      • Omaha, Nebraska, Forente stater, 68114
        • Children's Hospital and Medical Center of Omaha
    • Nevada
      • Las Vegas, Nevada, Forente stater, 89169
        • Nevada Cancer Research Foundation NCORP
    • New Hampshire
      • Lebanon, New Hampshire, Forente stater, 03756
        • Dartmouth Hitchcock Medical Center
    • New Jersey
      • Hackensack, New Jersey, Forente stater, 07601
        • Hackensack University Medical Center
      • Livingston, New Jersey, Forente stater, 07039
        • Saint Barnabas Medical Center
      • Morristown, New Jersey, Forente stater, 07960
        • Morristown Medical Center
      • New Brunswick, New Jersey, Forente stater, 08901
        • Saint Peter's University Hospital
      • New Brunswick, New Jersey, Forente stater, 08903
        • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital
      • Newark, New Jersey, Forente stater, 07112
        • Newark Beth Israel Medical Center
      • Paterson, New Jersey, Forente stater, 07503
        • Saint Joseph's Regional Medical Center
      • Summit, New Jersey, Forente stater, 07902
        • Overlook Hospital
    • New Mexico
      • Albuquerque, New Mexico, Forente stater, 87102
        • University of New Mexico Cancer Center
    • New York
      • Albany, New York, Forente stater, 12208
        • Albany Medical Center
      • Bronx, New York, Forente stater, 10467
        • Montefiore Medical Center - Moses Campus
      • Brooklyn, New York, Forente stater, 11219
        • Maimonides Medical Center
      • Brooklyn, New York, Forente stater, 11201
        • Brooklyn Hospital Center
      • Brooklyn, New York, Forente stater, 11212
        • Brookdale Hospital Medical Center
      • Buffalo, New York, Forente stater, 14263
        • Roswell Park Cancer Institute
      • Mineola, New York, Forente stater, 11501
        • NYU Winthrop Hospital
      • New Hyde Park, New York, Forente stater, 11040
        • The Steven and Alexandra Cohen Children's Medical Center of New York
      • New York, New York, Forente stater, 10029
        • Mount Sinai Hospital
      • New York, New York, Forente stater, 10065
        • NYP/Weill Cornell Medical Center
      • New York, New York, Forente stater, 10016
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
      • Stony Brook, New York, Forente stater, 11794
        • Stony Brook University Medical Center
      • Syracuse, New York, Forente stater, 13210
        • State University of New York Upstate Medical University
      • Valhalla, New York, Forente stater, 10595
        • New York Medical College
    • North Carolina
      • Asheville, North Carolina, Forente stater, 28801
        • Mission Hospital
      • Chapel Hill, North Carolina, Forente stater, 27599
        • UNC Lineberger Comprehensive Cancer Center
      • Charlotte, North Carolina, Forente stater, 28203
        • Carolinas Medical Center/Levine Cancer Institute
      • Charlotte, North Carolina, Forente stater, 28204
        • Novant Health Presbyterian Medical Center
      • Durham, North Carolina, Forente stater, 27710
        • Duke University Medical Center
      • Greenville, North Carolina, Forente stater, 27834
        • East Carolina University
      • Winston-Salem, North Carolina, Forente stater, 27157
        • Wake Forest University Health Sciences
    • North Dakota
      • Fargo, North Dakota, Forente stater, 58122
        • Sanford Broadway Medical Center
    • Ohio
      • Akron, Ohio, Forente stater, 44308
        • Children's Hospital Medical Center of Akron
      • Cincinnati, Ohio, Forente stater, 45229
        • Cincinnati Children's Hospital Medical Center
      • Cleveland, Ohio, Forente stater, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Forente stater, 44106
        • Rainbow Babies and Childrens Hospital
      • Columbus, Ohio, Forente stater, 43205
        • Nationwide Children's Hospital
      • Dayton, Ohio, Forente stater, 45404
        • Dayton Children's Hospital
      • Toledo, Ohio, Forente stater, 43606
        • ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
      • Toledo, Ohio, Forente stater, 43614
        • University of Toledo
      • Toledo, Ohio, Forente stater, 43608
        • Mercy Children's Hospital
      • Youngstown, Ohio, Forente stater, 44501
        • Tod Children's Hospital - Forum Health
    • Oklahoma
      • Oklahoma City, Oklahoma, Forente stater, 73104
        • University of Oklahoma Health Sciences Center
      • Tulsa, Oklahoma, Forente stater, 74136
        • Natalie Warren Bryant Cancer Center at Saint Francis
    • Oregon
      • Portland, Oregon, Forente stater, 97239
        • Oregon Health and Science University
      • Portland, Oregon, Forente stater, 97227
        • Legacy Emanuel Children's Hospital
      • Portland, Oregon, Forente stater, 97227
        • Legacy Emanuel Hospital and Health Center
    • Pennsylvania
      • Bethlehem, Pennsylvania, Forente stater, 18017
        • Lehigh Valley Hospital - Muhlenberg
      • Danville, Pennsylvania, Forente stater, 17822
        • Geisinger Medical Center
      • Hershey, Pennsylvania, Forente stater, 17033-0850
        • Penn State Milton S Hershey Medical Center
      • Hershey, Pennsylvania, Forente stater, 17033
        • Penn State Children's Hospital
      • Philadelphia, Pennsylvania, Forente stater, 19104
        • Children's Hospital of Philadelphia
      • Philadelphia, Pennsylvania, Forente stater, 19134
        • Saint Christopher's Hospital for Children
      • Philadelphia, Pennsylvania, Forente stater, 19104
        • Children's Oncology Group
      • Pittsburgh, Pennsylvania, Forente stater, 15224
        • Children's Hospital of Pittsburgh of UPMC
    • Rhode Island
      • Providence, Rhode Island, Forente stater, 02903
        • Rhode Island Hospital
    • South Carolina
      • Charleston, South Carolina, Forente stater, 29425
        • Medical University of South Carolina
      • Columbia, South Carolina, Forente stater, 29203
        • Prisma Health Richland Hospital
      • Greenville, South Carolina, Forente stater, 29605
        • BI-LO Charities Children's Cancer Center
      • Greenville, South Carolina, Forente stater, 29605
        • Greenville Cancer Treatment Center
    • South Dakota
      • Sioux Falls, South Dakota, Forente stater, 57117-5134
        • Sanford USD Medical Center - Sioux Falls
    • Tennessee
      • Chattanooga, Tennessee, Forente stater, 37403
        • T C Thompson Children's Hospital
      • Knoxville, Tennessee, Forente stater, 37916
        • East Tennessee Childrens Hospital
      • Nashville, Tennessee, Forente stater, 37232
        • Vanderbilt University/Ingram Cancer Center
    • Texas
      • Amarillo, Texas, Forente stater, 79106
        • Texas Tech University Health Sciences Center-Amarillo
      • Austin, Texas, Forente stater, 78723
        • Dell Children's Medical Center of Central Texas
      • Corpus Christi, Texas, Forente stater, 78411
        • Driscoll Children's Hospital
      • Dallas, Texas, Forente stater, 75390
        • UT Southwestern/Simmons Cancer Center-Dallas
      • Dallas, Texas, Forente stater, 75230
        • Medical City Dallas Hospital
      • Fort Worth, Texas, Forente stater, 76104
        • Cook Children's Medical Center
      • Galveston, Texas, Forente stater, 77555-0565
        • University of Texas Medical Branch
      • Houston, Texas, Forente stater, 77030
        • M D Anderson Cancer Center
      • Houston, Texas, Forente stater, 77030
        • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
      • Lubbock, Texas, Forente stater, 79410
        • Covenant Children's Hospital
      • San Antonio, Texas, Forente stater, 78229
        • University of Texas Health Science Center at San Antonio
      • San Antonio, Texas, Forente stater, 78229
        • Methodist Children's Hospital of South Texas
      • Temple, Texas, Forente stater, 76508
        • Scott and White Memorial Hospital
    • Utah
      • Salt Lake City, Utah, Forente stater, 84113
        • Primary Children's Hospital
    • Vermont
      • Burlington, Vermont, Forente stater, 05405
        • University of Vermont and State Agricultural College
    • Virginia
      • Charlottesville, Virginia, Forente stater, 22908
        • University of Virginia Cancer Center
      • Falls Church, Virginia, Forente stater, 22042
        • INOVA Fairfax Hospital
      • Norfolk, Virginia, Forente stater, 23507
        • Children's Hospital of The King's Daughters
      • Portsmouth, Virginia, Forente stater, 23708-2197
        • Naval Medical Center - Portsmouth
      • Richmond, Virginia, Forente stater, 23298
        • Virginia Commonwealth University/Massey Cancer Center
      • Roanoke, Virginia, Forente stater, 24014
        • Carilion Children's
    • Washington
      • Seattle, Washington, Forente stater, 98105
        • Seattle Children's Hospital
      • Spokane, Washington, Forente stater, 99204
        • Providence Sacred Heart Medical Center and Children's Hospital
      • Tacoma, Washington, Forente stater, 98405
        • Mary Bridge Children's Hospital and Health Center
      • Tacoma, Washington, Forente stater, 98431
        • Madigan Army Medical Center
    • West Virginia
      • Charleston, West Virginia, Forente stater, 25304
        • West Virginia University Charleston Division
      • Morgantown, West Virginia, Forente stater, 26506
        • West Virginia University Healthcare
    • Wisconsin
      • Green Bay, Wisconsin, Forente stater, 54301
        • Saint Vincent Hospital Cancer Center Green Bay
      • La Crosse, Wisconsin, Forente stater, 54601
        • Gundersen Lutheran Medical Center
      • Madison, Wisconsin, Forente stater, 53792
        • University of Wisconsin Hospital and Clinics
      • Marshfield, Wisconsin, Forente stater, 54449
        • Marshfield Medical Center-Marshfield
      • Milwaukee, Wisconsin, Forente stater, 53226
        • Children's Hospital of Wisconsin
      • Christchurch, New Zealand, 8011
        • Christchurch Hospital
      • Wellington, New Zealand, 6002
        • Wellington Children's Hospital
    • Auckland
      • Grafton, Auckland, New Zealand, 1145
        • Starship Children's Hospital
      • Bern, Sveits, 3010
        • Swiss Pediatric Oncology Group - Bern
      • Geneva, Sveits, 1205
        • Swiss Pediatric Oncology Group - Geneva
      • Lausanne, Sveits, 1011
        • Swiss Pediatric Oncology Group - Lausanne

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

1 år til 30 år (Barn, Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Must be eligible for and enrolled on classification study COG-AALL03B1
  • Newly diagnosed B-precursor acute lymphoblastic leukemia

    • WBC > 50,000/mm^3 for patients age 1 to 9
    • Any WBC for patients age 10 to 30 OR patients who have received prior steroid therapy OR patients with testicular disease
  • Whit blood cell (WBC) criteria:

    • Age 1 - 9 years: WBC >= 50,000/uL
    • Age 10 - 30 years: any WBC
    • Prior steroid therapy: any WBC
    • Testicular disease: any WBC
  • Patients shall have had no other prior cytotoxic chemotherapy with the exception of steroids and intrathecal cytarabine
  • Patients receiving prior steroid therapy (as described in AALL03B1) are eligible for study; the dose and duration of previous steroid therapy should be carefully documented
  • All patients and/or their parents or legal guardians must sign a written informed consent
  • All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

Exclusion Criteria:

  • Patients with Down syndrome are ineligible to enroll onto this study

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Arm I
Patients in arm I receive intrathecal cytarabine in week 1; infusions of vincristine and daunorubicin once a week in weeks 1-4; dexamethasone by mouth or infusion twice a day in weeks 1 and 2; intrathecal methotrexate in weeks 2 and 5 or 2-5; and an injection of pegaspargase in week 1.
Gitt IV
Andre navn:
  • Cerubidin
  • Cloridrato de Daunorubicina
  • Daunoblastin
  • Daunoblastina
  • Daunomycin hydroklorid
  • Daunomycin, hydroklorid
  • Daunorubicin.HCl
  • Daunorubicini Hydrochloridum
  • FI-6339
  • Ondena
  • RP-13057
  • Rubidomycin hydroklorid
  • Rubilem
Gitt IV
Andre navn:
  • Cytoksan
  • CTX
  • (-)-cyklofosfamid
  • 2H-1,3,2-oksazafosforin, 2-[bis(2-kloretyl)amino]tetrahydro-, 2-oksid, monohydrat
  • Carloxan
  • Ciclofosfamida
  • Ciklofosfamid
  • Cicloxal
  • Clafen
  • Claphene
  • CP monohydrat
  • CYCLO-celle
  • Sykloblastin
  • Cyclofosfam
  • Cyklofosfamid monohydrat
  • Cyclophosphamidum
  • Syklofosfan
  • Cyclophosphanum
  • Syklostin
  • Cytofosfan
  • Fosfaseron
  • Genoxal
  • Genuxal
  • Ledoxina
  • Mitoxan
  • Neosar
  • Revimmune
  • Syklofosfamid
  • WR- 138719
Gitt PO
Andre navn:
  • 6 MP
  • Purinethol
  • 3H-Purin-6-tiol
  • 6 Tiohypoksantin
  • 6 Tiopurin
  • 6-merkaptopurin
  • 6-merkaptopurinmonohydrat
  • 6-Purinethiol
  • 6-tiopurin
  • 6-tioksopurin
  • 6H-Purin-6-tion, 1,7-dihydro- (9Cl)
  • 7-merkapto-1,3,4,6-tetrazainden
  • Alti-merkaptopurin
  • Azatiopurin
  • Bw 57-323H
  • Flocofil
  • Ismipur
  • Leukerin
  • Leupurin
  • Mercaleukim
  • Mercaleukin
  • Mercaptina
  • Mercaptopurinum
  • Mercapurin
  • Mern
  • NCI-C04886
  • Puri-Nethol
  • Purimetol
  • Purin, 6-merkapto-
  • Purin-6-tiol (8CI)
  • Purin-6-tiol, monohydrat
  • Purinethiol
  • U-4748
  • WR-2785
Gitt IV
Andre navn:
  • Oncovin
  • Kyocristine
  • Leurocristine Sulfate
  • Leurocristine, sulfat
  • Vincasar
  • Vincosid
  • Vincrex
  • Vinkristin, sulfat
Gitt IV
Andre navn:
  • Adriamycin
  • 5,12-naftacendion, 10-[(3-amino-2,3,6-trideoksy-alfa-L-lyxo-heksopyranosyl)oksy]-7,8, 9,10-tetrahydro-6,8,11-trihydroksy -8-(hydroksyacetyl)-1-metoksy-, hydroklorid, (8S-cis)- (9Cl)
  • ADM
  • Adriacin
  • Adriamycin hydroklorid
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROKLORID
  • Adriblastina
  • Adriblastin
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin HCl
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroksydaunorubicin
  • Rubex
Gitt PO eller IV
Andre navn:
  • Dekadron
  • Aacidexam
  • Adexone
  • Aknichthol Dexa
  • Alba-Dex
  • Alin
  • Alin Depot
  • Alin Oftalmico
  • Amplidermis
  • Anemul mono
  • Auricularum
  • Auxiloson
  • Baycadron
  • Baycuten
  • Baycuten N
  • Cortidexason
  • Cortisumman
  • Decacort
  • Decadrol
  • Decadron DP
  • Decalix
  • Decameth
  • Decasone R.p.
  • Dectancyl
  • Dekacort
  • Deltafluoren
  • Deronil
  • Desametason
  • Desameton
  • Dexa-Mamallet
  • Dexa-Rhinosan
  • Dexa-Scheroson
  • Dexa-sinus
  • Dexacortal
  • Dexacortin
  • Dexafarma
  • Dexafluoren
  • Dexalocal
  • Deksamekortin
  • Dexameth
  • Deksametason Intensol
  • Deksametasonum
  • Dexamonozon
  • Dexapos
  • Dexinoral
  • Dexone
  • Dinormon
  • Dxevo
  • Fluorodelta
  • Fortecortin
  • Gammacorten
  • Heksadekadrol
  • Heksadrol
  • Lokalison-F
  • Loverine
  • Metylfluorprednisolon
  • Millicorten
  • Mymetason
  • Orgadrone
  • Spersadex
  • TaperDex
  • Visumetazon
  • ZoDex
Gitt PO
Andre navn:
  • 6-TG
  • 2-amino 6 MP
  • 2-amino-1,7-dihydro-6H-purin-6-tion
  • 2-amino-6-merkaptopurin
  • 2-amino-6-purinethiol
  • 2-aminopurin-6-tiol
  • 2-aminopurin-6(1H)-tion
  • 2-aminopurin-6-tiol hemihydrat
  • 2-merkapto-6-aminopurin
  • 6-amino-2-merkaptopurin
  • 6-merkapto-2-aminopurin
  • 6-merkaptoguanin
  • 6H-Purin-6-tion, 2-amino-1,7-dihydro- (9Cl)
  • BW 5071
  • Lanvis
  • Tabloid
  • Tioguanin hemihydrat
  • Tioguaninhydrat
  • Tioguanin
  • Tioguanine
  • Velkommen U3B
  • WR-1141
  • X 27
Gjennomgå strålebehandling
Andre navn:
  • Kreft Strålebehandling
  • ENERGY_TYPE
  • Bestråle
  • Bestrålt
  • Bestråling
  • Stråling
  • Stråleterapi, NOS
  • Radioterapeutika
  • Strålebehandling
  • RT
  • Terapi, stråling
Gitt IM
Andre navn:
  • L-asparaginase med polyetylenglykol
  • Oncaspar
  • Oncaspar-IV
  • PEG-asparaginase
  • PEG-L-asparaginase
  • PEG-L-Asparaginase (Enzon - Kyowa Hakko)
  • PEGLA
  • Polyetylenglykol L-asparaginase
  • Polyetylenglykol-L-asparaginase
Gitt IT eller IV
Andre navn:
  • Abitrexate
  • Folex
  • Mexate
  • MTX
  • Alfa-metopterin
  • Amethopterin
  • Brimexat
  • CL 14377
  • CL-14377
  • Emtexate
  • Emthexat
  • Emthexate
  • Farmitrexat
  • Fauldexato
  • Folex PFS
  • Lantarel
  • Ledertreksat
  • Lumexon
  • Maxtrex
  • Medsatrexate
  • Metex
  • Metoblastin
  • Metotreksat LPF
  • Metotreksat Metylaminopterin
  • Metotrexatum
  • Metotrexato
  • Metrotex
  • Mexate-AQ
  • Novatrex
  • Reumatrex
  • Texate
  • Tremetex
  • Trexeron
  • Trixilem
  • WR-19039
Given IT, SC, or IV
Andre navn:
  • P-Cytosin-arabinosid
  • 1-P-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinon
  • 1-B-D-Arabinofuranosylcytosin
  • 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinon
  • 1-Beta-D-arabinofuranosylcytosin
  • 1P-D-Arabinofuranosylcytosin
  • 2(1H)-pyrimidinon, 4-amino-1-beta-D-arabinofuranosyl-
  • 2(1H)-pyrimidinon, 4-amino-lß-D-arabinofuranosyl-
  • Alexan
  • Ara-C
  • ARA-celle
  • Arabine
  • Arabinofuranosylcytosin
  • Arabinosylcytosin
  • Aracytidin
  • Aracytin
  • Aracytine
  • Beta-Cytosine Arabinoside
  • CHX-3311
  • Cytarabinum
  • Cytarbel
  • Cytosar
  • Cytosin Arabinoside
  • Cytosin-p-arabinosid
  • Cytosin-beta-arabinosid
  • Erpalfa
  • Starasid
  • Tarabin PFS
  • U 19920
  • U-19920
  • Udicil
  • WR-28453
Aktiv komparator: Arm II
Patients in arm II will receive intrathecal cytarabine in week 1; infusions of vincristine and daunorubicin once a week in weeks 1-4; dexamethasone by mouth or infusion twice a day in weeks 1 and 2; intrathecal methotrexate in weeks 2 and 5 or 2-5; and an injection of pegaspargase in week 1.
Gitt IV
Andre navn:
  • Cerubidin
  • Cloridrato de Daunorubicina
  • Daunoblastin
  • Daunoblastina
  • Daunomycin hydroklorid
  • Daunomycin, hydroklorid
  • Daunorubicin.HCl
  • Daunorubicini Hydrochloridum
  • FI-6339
  • Ondena
  • RP-13057
  • Rubidomycin hydroklorid
  • Rubilem
Gitt IV
Andre navn:
  • Cytoksan
  • CTX
  • (-)-cyklofosfamid
  • 2H-1,3,2-oksazafosforin, 2-[bis(2-kloretyl)amino]tetrahydro-, 2-oksid, monohydrat
  • Carloxan
  • Ciclofosfamida
  • Ciklofosfamid
  • Cicloxal
  • Clafen
  • Claphene
  • CP monohydrat
  • CYCLO-celle
  • Sykloblastin
  • Cyclofosfam
  • Cyklofosfamid monohydrat
  • Cyclophosphamidum
  • Syklofosfan
  • Cyclophosphanum
  • Syklostin
  • Cytofosfan
  • Fosfaseron
  • Genoxal
  • Genuxal
  • Ledoxina
  • Mitoxan
  • Neosar
  • Revimmune
  • Syklofosfamid
  • WR- 138719
Gitt PO
Andre navn:
  • 6 MP
  • Purinethol
  • 3H-Purin-6-tiol
  • 6 Tiohypoksantin
  • 6 Tiopurin
  • 6-merkaptopurin
  • 6-merkaptopurinmonohydrat
  • 6-Purinethiol
  • 6-tiopurin
  • 6-tioksopurin
  • 6H-Purin-6-tion, 1,7-dihydro- (9Cl)
  • 7-merkapto-1,3,4,6-tetrazainden
  • Alti-merkaptopurin
  • Azatiopurin
  • Bw 57-323H
  • Flocofil
  • Ismipur
  • Leukerin
  • Leupurin
  • Mercaleukim
  • Mercaleukin
  • Mercaptina
  • Mercaptopurinum
  • Mercapurin
  • Mern
  • NCI-C04886
  • Puri-Nethol
  • Purimetol
  • Purin, 6-merkapto-
  • Purin-6-tiol (8CI)
  • Purin-6-tiol, monohydrat
  • Purinethiol
  • U-4748
  • WR-2785
Gitt IV
Andre navn:
  • Oncovin
  • Kyocristine
  • Leurocristine Sulfate
  • Leurocristine, sulfat
  • Vincasar
  • Vincosid
  • Vincrex
  • Vinkristin, sulfat
Gitt IV
Andre navn:
  • Adriamycin
  • 5,12-naftacendion, 10-[(3-amino-2,3,6-trideoksy-alfa-L-lyxo-heksopyranosyl)oksy]-7,8, 9,10-tetrahydro-6,8,11-trihydroksy -8-(hydroksyacetyl)-1-metoksy-, hydroklorid, (8S-cis)- (9Cl)
  • ADM
  • Adriacin
  • Adriamycin hydroklorid
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROKLORID
  • Adriblastina
  • Adriblastin
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin HCl
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroksydaunorubicin
  • Rubex
Gitt PO eller IV
Andre navn:
  • Dekadron
  • Aacidexam
  • Adexone
  • Aknichthol Dexa
  • Alba-Dex
  • Alin
  • Alin Depot
  • Alin Oftalmico
  • Amplidermis
  • Anemul mono
  • Auricularum
  • Auxiloson
  • Baycadron
  • Baycuten
  • Baycuten N
  • Cortidexason
  • Cortisumman
  • Decacort
  • Decadrol
  • Decadron DP
  • Decalix
  • Decameth
  • Decasone R.p.
  • Dectancyl
  • Dekacort
  • Deltafluoren
  • Deronil
  • Desametason
  • Desameton
  • Dexa-Mamallet
  • Dexa-Rhinosan
  • Dexa-Scheroson
  • Dexa-sinus
  • Dexacortal
  • Dexacortin
  • Dexafarma
  • Dexafluoren
  • Dexalocal
  • Deksamekortin
  • Dexameth
  • Deksametason Intensol
  • Deksametasonum
  • Dexamonozon
  • Dexapos
  • Dexinoral
  • Dexone
  • Dinormon
  • Dxevo
  • Fluorodelta
  • Fortecortin
  • Gammacorten
  • Heksadekadrol
  • Heksadrol
  • Lokalison-F
  • Loverine
  • Metylfluorprednisolon
  • Millicorten
  • Mymetason
  • Orgadrone
  • Spersadex
  • TaperDex
  • Visumetazon
  • ZoDex
Gitt PO
Andre navn:
  • 6-TG
  • 2-amino 6 MP
  • 2-amino-1,7-dihydro-6H-purin-6-tion
  • 2-amino-6-merkaptopurin
  • 2-amino-6-purinethiol
  • 2-aminopurin-6-tiol
  • 2-aminopurin-6(1H)-tion
  • 2-aminopurin-6-tiol hemihydrat
  • 2-merkapto-6-aminopurin
  • 6-amino-2-merkaptopurin
  • 6-merkapto-2-aminopurin
  • 6-merkaptoguanin
  • 6H-Purin-6-tion, 2-amino-1,7-dihydro- (9Cl)
  • BW 5071
  • Lanvis
  • Tabloid
  • Tioguanin hemihydrat
  • Tioguaninhydrat
  • Tioguanin
  • Tioguanine
  • Velkommen U3B
  • WR-1141
  • X 27
Gjennomgå strålebehandling
Andre navn:
  • Kreft Strålebehandling
  • ENERGY_TYPE
  • Bestråle
  • Bestrålt
  • Bestråling
  • Stråling
  • Stråleterapi, NOS
  • Radioterapeutika
  • Strålebehandling
  • RT
  • Terapi, stråling
Gitt IV
Andre navn:
  • Wellcovorin
  • folinsyre
  • Adinepar
  • Calcifolin
  • Kalsium (6S)-folinat
  • Kalsiumfolinat
  • Kalsiumleukovorin
  • Calfolex
  • Calinat
  • Cehafolin
  • Citofolin
  • Citrec
  • Citrovorum faktor
  • Cromatonbic Folinico
  • Dalisol
  • Disintox
  • Divical
  • Ecofol
  • Emovis
  • Faktor, Citrovorum
  • Flynoken A
  • Folaren
  • Folaxin
  • FOLI-celle
  • Foliben
  • Folidan
  • Folidar
  • Folinac
  • Folinat kalsium
  • Folinsyre Kalsium Salt Pentahydrat
  • Folinoral
  • Folinvit
  • Foliplus
  • Folix
  • Imo
  • Lederfolat
  • Lederfolin
  • Leucosar
  • leukovorin
  • Rescufolin
  • Rescuvolin
  • Tonofolin
Gitt IM
Andre navn:
  • L-asparaginase med polyetylenglykol
  • Oncaspar
  • Oncaspar-IV
  • PEG-asparaginase
  • PEG-L-asparaginase
  • PEG-L-Asparaginase (Enzon - Kyowa Hakko)
  • PEGLA
  • Polyetylenglykol L-asparaginase
  • Polyetylenglykol-L-asparaginase
Gitt IT eller IV
Andre navn:
  • Abitrexate
  • Folex
  • Mexate
  • MTX
  • Alfa-metopterin
  • Amethopterin
  • Brimexat
  • CL 14377
  • CL-14377
  • Emtexate
  • Emthexat
  • Emthexate
  • Farmitrexat
  • Fauldexato
  • Folex PFS
  • Lantarel
  • Ledertreksat
  • Lumexon
  • Maxtrex
  • Medsatrexate
  • Metex
  • Metoblastin
  • Metotreksat LPF
  • Metotreksat Metylaminopterin
  • Metotrexatum
  • Metotrexato
  • Metrotex
  • Mexate-AQ
  • Novatrex
  • Reumatrex
  • Texate
  • Tremetex
  • Trexeron
  • Trixilem
  • WR-19039
Given IT, SC, or IV
Andre navn:
  • P-Cytosin-arabinosid
  • 1-P-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinon
  • 1-B-D-Arabinofuranosylcytosin
  • 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinon
  • 1-Beta-D-arabinofuranosylcytosin
  • 1P-D-Arabinofuranosylcytosin
  • 2(1H)-pyrimidinon, 4-amino-1-beta-D-arabinofuranosyl-
  • 2(1H)-pyrimidinon, 4-amino-lß-D-arabinofuranosyl-
  • Alexan
  • Ara-C
  • ARA-celle
  • Arabine
  • Arabinofuranosylcytosin
  • Arabinosylcytosin
  • Aracytidin
  • Aracytin
  • Aracytine
  • Beta-Cytosine Arabinoside
  • CHX-3311
  • Cytarabinum
  • Cytarbel
  • Cytosar
  • Cytosin Arabinoside
  • Cytosin-p-arabinosid
  • Cytosin-beta-arabinosid
  • Erpalfa
  • Starasid
  • Tarabin PFS
  • U 19920
  • U-19920
  • Udicil
  • WR-28453
Eksperimentell: Arm III

Patients in arm III will receive cytarabine, vincristine, daunorubicin, and pegaspargase as in groups one and two. They will also receive prednisone by mouth or infusion twice a day in weeks 1-4 and intrathecal methotrexate in weeks 2 and 5.

Some patients in all groups may receive induction therapy for 2 additional weeks. Beginning in week 6 or 7, patients may receive combination chemotherapy by infusion, injection, intrathecally, and by mouth for up to 8 weeks.

Gitt IV
Andre navn:
  • Cerubidin
  • Cloridrato de Daunorubicina
  • Daunoblastin
  • Daunoblastina
  • Daunomycin hydroklorid
  • Daunomycin, hydroklorid
  • Daunorubicin.HCl
  • Daunorubicini Hydrochloridum
  • FI-6339
  • Ondena
  • RP-13057
  • Rubidomycin hydroklorid
  • Rubilem
Gitt IV
Andre navn:
  • Cytoksan
  • CTX
  • (-)-cyklofosfamid
  • 2H-1,3,2-oksazafosforin, 2-[bis(2-kloretyl)amino]tetrahydro-, 2-oksid, monohydrat
  • Carloxan
  • Ciclofosfamida
  • Ciklofosfamid
  • Cicloxal
  • Clafen
  • Claphene
  • CP monohydrat
  • CYCLO-celle
  • Sykloblastin
  • Cyclofosfam
  • Cyklofosfamid monohydrat
  • Cyclophosphamidum
  • Syklofosfan
  • Cyclophosphanum
  • Syklostin
  • Cytofosfan
  • Fosfaseron
  • Genoxal
  • Genuxal
  • Ledoxina
  • Mitoxan
  • Neosar
  • Revimmune
  • Syklofosfamid
  • WR- 138719
Gitt PO
Andre navn:
  • 6 MP
  • Purinethol
  • 3H-Purin-6-tiol
  • 6 Tiohypoksantin
  • 6 Tiopurin
  • 6-merkaptopurin
  • 6-merkaptopurinmonohydrat
  • 6-Purinethiol
  • 6-tiopurin
  • 6-tioksopurin
  • 6H-Purin-6-tion, 1,7-dihydro- (9Cl)
  • 7-merkapto-1,3,4,6-tetrazainden
  • Alti-merkaptopurin
  • Azatiopurin
  • Bw 57-323H
  • Flocofil
  • Ismipur
  • Leukerin
  • Leupurin
  • Mercaleukim
  • Mercaleukin
  • Mercaptina
  • Mercaptopurinum
  • Mercapurin
  • Mern
  • NCI-C04886
  • Puri-Nethol
  • Purimetol
  • Purin, 6-merkapto-
  • Purin-6-tiol (8CI)
  • Purin-6-tiol, monohydrat
  • Purinethiol
  • U-4748
  • WR-2785
Gitt IV
Andre navn:
  • Oncovin
  • Kyocristine
  • Leurocristine Sulfate
  • Leurocristine, sulfat
  • Vincasar
  • Vincosid
  • Vincrex
  • Vinkristin, sulfat
Gitt IV
Andre navn:
  • Adriamycin
  • 5,12-naftacendion, 10-[(3-amino-2,3,6-trideoksy-alfa-L-lyxo-heksopyranosyl)oksy]-7,8, 9,10-tetrahydro-6,8,11-trihydroksy -8-(hydroksyacetyl)-1-metoksy-, hydroklorid, (8S-cis)- (9Cl)
  • ADM
  • Adriacin
  • Adriamycin hydroklorid
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROKLORID
  • Adriblastina
  • Adriblastin
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin HCl
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroksydaunorubicin
  • Rubex
Gitt PO eller IV
Andre navn:
  • Dekadron
  • Aacidexam
  • Adexone
  • Aknichthol Dexa
  • Alba-Dex
  • Alin
  • Alin Depot
  • Alin Oftalmico
  • Amplidermis
  • Anemul mono
  • Auricularum
  • Auxiloson
  • Baycadron
  • Baycuten
  • Baycuten N
  • Cortidexason
  • Cortisumman
  • Decacort
  • Decadrol
  • Decadron DP
  • Decalix
  • Decameth
  • Decasone R.p.
  • Dectancyl
  • Dekacort
  • Deltafluoren
  • Deronil
  • Desametason
  • Desameton
  • Dexa-Mamallet
  • Dexa-Rhinosan
  • Dexa-Scheroson
  • Dexa-sinus
  • Dexacortal
  • Dexacortin
  • Dexafarma
  • Dexafluoren
  • Dexalocal
  • Deksamekortin
  • Dexameth
  • Deksametason Intensol
  • Deksametasonum
  • Dexamonozon
  • Dexapos
  • Dexinoral
  • Dexone
  • Dinormon
  • Dxevo
  • Fluorodelta
  • Fortecortin
  • Gammacorten
  • Heksadekadrol
  • Heksadrol
  • Lokalison-F
  • Loverine
  • Metylfluorprednisolon
  • Millicorten
  • Mymetason
  • Orgadrone
  • Spersadex
  • TaperDex
  • Visumetazon
  • ZoDex
Gitt PO
Andre navn:
  • 6-TG
  • 2-amino 6 MP
  • 2-amino-1,7-dihydro-6H-purin-6-tion
  • 2-amino-6-merkaptopurin
  • 2-amino-6-purinethiol
  • 2-aminopurin-6-tiol
  • 2-aminopurin-6(1H)-tion
  • 2-aminopurin-6-tiol hemihydrat
  • 2-merkapto-6-aminopurin
  • 6-amino-2-merkaptopurin
  • 6-merkapto-2-aminopurin
  • 6-merkaptoguanin
  • 6H-Purin-6-tion, 2-amino-1,7-dihydro- (9Cl)
  • BW 5071
  • Lanvis
  • Tabloid
  • Tioguanin hemihydrat
  • Tioguaninhydrat
  • Tioguanin
  • Tioguanine
  • Velkommen U3B
  • WR-1141
  • X 27
Gjennomgå strålebehandling
Andre navn:
  • Kreft Strålebehandling
  • ENERGY_TYPE
  • Bestråle
  • Bestrålt
  • Bestråling
  • Stråling
  • Stråleterapi, NOS
  • Radioterapeutika
  • Strålebehandling
  • RT
  • Terapi, stråling
Gitt PO eller IV
Andre navn:
  • Deltasone
  • Orasone
  • 61-kortison
  • 1,2-dehydrokortison
  • Adasone
  • Cortancyl
  • Dacortin
  • DeCortin
  • Decortisyl
  • Decorton
  • Delta 1-kortison
  • Delta-Dome
  • Deltacortene
  • Deltakortison
  • Deltadehydrokortison
  • Deltison
  • Delta
  • Econosone
  • Lisacort
  • Meprosona-F
  • Metakortandracin
  • Meticorten
  • Ofisolona
  • Panafcort
  • Panasol-S
  • Paracort
  • Perrigo Prednison
  • PRED
  • Predicor
  • Predicorten
  • Prednicen-M
  • Prednicort
  • Prednidib
  • Prednilonga
  • Predniment
  • Prednison Intensol
  • Prednisonum
  • Predniton
  • Promifen
  • Rayos
  • Servisone
  • SK-Prednison
Gitt IM
Andre navn:
  • L-asparaginase med polyetylenglykol
  • Oncaspar
  • Oncaspar-IV
  • PEG-asparaginase
  • PEG-L-asparaginase
  • PEG-L-Asparaginase (Enzon - Kyowa Hakko)
  • PEGLA
  • Polyetylenglykol L-asparaginase
  • Polyetylenglykol-L-asparaginase
Gitt IT eller IV
Andre navn:
  • Abitrexate
  • Folex
  • Mexate
  • MTX
  • Alfa-metopterin
  • Amethopterin
  • Brimexat
  • CL 14377
  • CL-14377
  • Emtexate
  • Emthexat
  • Emthexate
  • Farmitrexat
  • Fauldexato
  • Folex PFS
  • Lantarel
  • Ledertreksat
  • Lumexon
  • Maxtrex
  • Medsatrexate
  • Metex
  • Metoblastin
  • Metotreksat LPF
  • Metotreksat Metylaminopterin
  • Metotrexatum
  • Metotrexato
  • Metrotex
  • Mexate-AQ
  • Novatrex
  • Reumatrex
  • Texate
  • Tremetex
  • Trexeron
  • Trixilem
  • WR-19039
Given IT, SC, or IV
Andre navn:
  • P-Cytosin-arabinosid
  • 1-P-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinon
  • 1-B-D-Arabinofuranosylcytosin
  • 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinon
  • 1-Beta-D-arabinofuranosylcytosin
  • 1P-D-Arabinofuranosylcytosin
  • 2(1H)-pyrimidinon, 4-amino-1-beta-D-arabinofuranosyl-
  • 2(1H)-pyrimidinon, 4-amino-lß-D-arabinofuranosyl-
  • Alexan
  • Ara-C
  • ARA-celle
  • Arabine
  • Arabinofuranosylcytosin
  • Arabinosylcytosin
  • Aracytidin
  • Aracytin
  • Aracytine
  • Beta-Cytosine Arabinoside
  • CHX-3311
  • Cytarabinum
  • Cytarbel
  • Cytosar
  • Cytosin Arabinoside
  • Cytosin-p-arabinosid
  • Cytosin-beta-arabinosid
  • Erpalfa
  • Starasid
  • Tarabin PFS
  • U 19920
  • U-19920
  • Udicil
  • WR-28453
Eksperimentell: Arm IV

Patients in arm IV will receive cytarabine, vincristine, daunorubicin, and pegaspargase as in groups one and two. They will also receive prednisone by mouth or infusion twice a day in weeks 1-4 and intrathecal methotrexate in weeks 2 and 5.

Some patients in all groups may receive induction therapy for 2 additional weeks. Beginning in week 6 or 7, patients may receive combination chemotherapy by infusion, injection, intrathecally, and by mouth for up to 8 weeks.

Gitt IV
Andre navn:
  • Cerubidin
  • Cloridrato de Daunorubicina
  • Daunoblastin
  • Daunoblastina
  • Daunomycin hydroklorid
  • Daunomycin, hydroklorid
  • Daunorubicin.HCl
  • Daunorubicini Hydrochloridum
  • FI-6339
  • Ondena
  • RP-13057
  • Rubidomycin hydroklorid
  • Rubilem
Gitt IV
Andre navn:
  • Cytoksan
  • CTX
  • (-)-cyklofosfamid
  • 2H-1,3,2-oksazafosforin, 2-[bis(2-kloretyl)amino]tetrahydro-, 2-oksid, monohydrat
  • Carloxan
  • Ciclofosfamida
  • Ciklofosfamid
  • Cicloxal
  • Clafen
  • Claphene
  • CP monohydrat
  • CYCLO-celle
  • Sykloblastin
  • Cyclofosfam
  • Cyklofosfamid monohydrat
  • Cyclophosphamidum
  • Syklofosfan
  • Cyclophosphanum
  • Syklostin
  • Cytofosfan
  • Fosfaseron
  • Genoxal
  • Genuxal
  • Ledoxina
  • Mitoxan
  • Neosar
  • Revimmune
  • Syklofosfamid
  • WR- 138719
Gitt PO
Andre navn:
  • 6 MP
  • Purinethol
  • 3H-Purin-6-tiol
  • 6 Tiohypoksantin
  • 6 Tiopurin
  • 6-merkaptopurin
  • 6-merkaptopurinmonohydrat
  • 6-Purinethiol
  • 6-tiopurin
  • 6-tioksopurin
  • 6H-Purin-6-tion, 1,7-dihydro- (9Cl)
  • 7-merkapto-1,3,4,6-tetrazainden
  • Alti-merkaptopurin
  • Azatiopurin
  • Bw 57-323H
  • Flocofil
  • Ismipur
  • Leukerin
  • Leupurin
  • Mercaleukim
  • Mercaleukin
  • Mercaptina
  • Mercaptopurinum
  • Mercapurin
  • Mern
  • NCI-C04886
  • Puri-Nethol
  • Purimetol
  • Purin, 6-merkapto-
  • Purin-6-tiol (8CI)
  • Purin-6-tiol, monohydrat
  • Purinethiol
  • U-4748
  • WR-2785
Gitt IV
Andre navn:
  • Oncovin
  • Kyocristine
  • Leurocristine Sulfate
  • Leurocristine, sulfat
  • Vincasar
  • Vincosid
  • Vincrex
  • Vinkristin, sulfat
Gitt IV
Andre navn:
  • Adriamycin
  • 5,12-naftacendion, 10-[(3-amino-2,3,6-trideoksy-alfa-L-lyxo-heksopyranosyl)oksy]-7,8, 9,10-tetrahydro-6,8,11-trihydroksy -8-(hydroksyacetyl)-1-metoksy-, hydroklorid, (8S-cis)- (9Cl)
  • ADM
  • Adriacin
  • Adriamycin hydroklorid
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROKLORID
  • Adriblastina
  • Adriblastin
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin HCl
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroksydaunorubicin
  • Rubex
Gitt PO eller IV
Andre navn:
  • Dekadron
  • Aacidexam
  • Adexone
  • Aknichthol Dexa
  • Alba-Dex
  • Alin
  • Alin Depot
  • Alin Oftalmico
  • Amplidermis
  • Anemul mono
  • Auricularum
  • Auxiloson
  • Baycadron
  • Baycuten
  • Baycuten N
  • Cortidexason
  • Cortisumman
  • Decacort
  • Decadrol
  • Decadron DP
  • Decalix
  • Decameth
  • Decasone R.p.
  • Dectancyl
  • Dekacort
  • Deltafluoren
  • Deronil
  • Desametason
  • Desameton
  • Dexa-Mamallet
  • Dexa-Rhinosan
  • Dexa-Scheroson
  • Dexa-sinus
  • Dexacortal
  • Dexacortin
  • Dexafarma
  • Dexafluoren
  • Dexalocal
  • Deksamekortin
  • Dexameth
  • Deksametason Intensol
  • Deksametasonum
  • Dexamonozon
  • Dexapos
  • Dexinoral
  • Dexone
  • Dinormon
  • Dxevo
  • Fluorodelta
  • Fortecortin
  • Gammacorten
  • Heksadekadrol
  • Heksadrol
  • Lokalison-F
  • Loverine
  • Metylfluorprednisolon
  • Millicorten
  • Mymetason
  • Orgadrone
  • Spersadex
  • TaperDex
  • Visumetazon
  • ZoDex
Gitt PO
Andre navn:
  • 6-TG
  • 2-amino 6 MP
  • 2-amino-1,7-dihydro-6H-purin-6-tion
  • 2-amino-6-merkaptopurin
  • 2-amino-6-purinethiol
  • 2-aminopurin-6-tiol
  • 2-aminopurin-6(1H)-tion
  • 2-aminopurin-6-tiol hemihydrat
  • 2-merkapto-6-aminopurin
  • 6-amino-2-merkaptopurin
  • 6-merkapto-2-aminopurin
  • 6-merkaptoguanin
  • 6H-Purin-6-tion, 2-amino-1,7-dihydro- (9Cl)
  • BW 5071
  • Lanvis
  • Tabloid
  • Tioguanin hemihydrat
  • Tioguaninhydrat
  • Tioguanin
  • Tioguanine
  • Velkommen U3B
  • WR-1141
  • X 27
Gjennomgå strålebehandling
Andre navn:
  • Kreft Strålebehandling
  • ENERGY_TYPE
  • Bestråle
  • Bestrålt
  • Bestråling
  • Stråling
  • Stråleterapi, NOS
  • Radioterapeutika
  • Strålebehandling
  • RT
  • Terapi, stråling
Gitt PO eller IV
Andre navn:
  • Deltasone
  • Orasone
  • 61-kortison
  • 1,2-dehydrokortison
  • Adasone
  • Cortancyl
  • Dacortin
  • DeCortin
  • Decortisyl
  • Decorton
  • Delta 1-kortison
  • Delta-Dome
  • Deltacortene
  • Deltakortison
  • Deltadehydrokortison
  • Deltison
  • Delta
  • Econosone
  • Lisacort
  • Meprosona-F
  • Metakortandracin
  • Meticorten
  • Ofisolona
  • Panafcort
  • Panasol-S
  • Paracort
  • Perrigo Prednison
  • PRED
  • Predicor
  • Predicorten
  • Prednicen-M
  • Prednicort
  • Prednidib
  • Prednilonga
  • Predniment
  • Prednison Intensol
  • Prednisonum
  • Predniton
  • Promifen
  • Rayos
  • Servisone
  • SK-Prednison
Gitt IV
Andre navn:
  • Wellcovorin
  • folinsyre
  • Adinepar
  • Calcifolin
  • Kalsium (6S)-folinat
  • Kalsiumfolinat
  • Kalsiumleukovorin
  • Calfolex
  • Calinat
  • Cehafolin
  • Citofolin
  • Citrec
  • Citrovorum faktor
  • Cromatonbic Folinico
  • Dalisol
  • Disintox
  • Divical
  • Ecofol
  • Emovis
  • Faktor, Citrovorum
  • Flynoken A
  • Folaren
  • Folaxin
  • FOLI-celle
  • Foliben
  • Folidan
  • Folidar
  • Folinac
  • Folinat kalsium
  • Folinsyre Kalsium Salt Pentahydrat
  • Folinoral
  • Folinvit
  • Foliplus
  • Folix
  • Imo
  • Lederfolat
  • Lederfolin
  • Leucosar
  • leukovorin
  • Rescufolin
  • Rescuvolin
  • Tonofolin
Gitt IM
Andre navn:
  • L-asparaginase med polyetylenglykol
  • Oncaspar
  • Oncaspar-IV
  • PEG-asparaginase
  • PEG-L-asparaginase
  • PEG-L-Asparaginase (Enzon - Kyowa Hakko)
  • PEGLA
  • Polyetylenglykol L-asparaginase
  • Polyetylenglykol-L-asparaginase
Gitt IT eller IV
Andre navn:
  • Abitrexate
  • Folex
  • Mexate
  • MTX
  • Alfa-metopterin
  • Amethopterin
  • Brimexat
  • CL 14377
  • CL-14377
  • Emtexate
  • Emthexat
  • Emthexate
  • Farmitrexat
  • Fauldexato
  • Folex PFS
  • Lantarel
  • Ledertreksat
  • Lumexon
  • Maxtrex
  • Medsatrexate
  • Metex
  • Metoblastin
  • Metotreksat LPF
  • Metotreksat Metylaminopterin
  • Metotrexatum
  • Metotrexato
  • Metrotex
  • Mexate-AQ
  • Novatrex
  • Reumatrex
  • Texate
  • Tremetex
  • Trexeron
  • Trixilem
  • WR-19039
Given IT, SC, or IV
Andre navn:
  • P-Cytosin-arabinosid
  • 1-P-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinon
  • 1-B-D-Arabinofuranosylcytosin
  • 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinon
  • 1-Beta-D-arabinofuranosylcytosin
  • 1P-D-Arabinofuranosylcytosin
  • 2(1H)-pyrimidinon, 4-amino-1-beta-D-arabinofuranosyl-
  • 2(1H)-pyrimidinon, 4-amino-lß-D-arabinofuranosyl-
  • Alexan
  • Ara-C
  • ARA-celle
  • Arabine
  • Arabinofuranosylcytosin
  • Arabinosylcytosin
  • Aracytidin
  • Aracytin
  • Aracytine
  • Beta-Cytosine Arabinoside
  • CHX-3311
  • Cytarabinum
  • Cytarbel
  • Cytosar
  • Cytosin Arabinoside
  • Cytosin-p-arabinosid
  • Cytosin-beta-arabinosid
  • Erpalfa
  • Starasid
  • Tarabin PFS
  • U 19920
  • U-19920
  • Udicil
  • WR-28453

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Comparison of the Increase in Cure Rate of High Risk ALL Without Causing More Serious Side Effects Between Interventions
Tidsramme: 5 years
Event Free Probability.
5 years

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Correlation of Minimal Residual Disease (MRD) Positive With Overall Survival (OS)
Tidsramme: 5 Years
Bone marrow MRD status is defined as positive with >= 0.1 detectable leukemia cells, and negative with < 0.1 detectable leukemia cells.
5 Years
Correlation of Minimal Residual Disease (MRD) Negative With Overall Survival (OS).
Tidsramme: 5 years
Bone marrow MRD status is defined as negative with < .01 detectable leukemia cells.
5 years
Correlation of Early Marrow Response Status With MRD Positive.
Tidsramme: Day 29
Bone marrow status is defined as: M1: < 5% lymphoblasts; M2: 5-25% lymphoblasts; M3: > 25% lymphoblasts. Bone marrow MRD status is defined as positive with >= 0.1 detectable leukemia cells, and negative with < 0.1 detectable leukemia cells.
Day 29
Correlation of Early Marrow Response Status With MRD Negative.
Tidsramme: Day 29
Bone marrow status is defined as: M1: < 5% lymphoblasts; M2: 5-25% lymphoblasts; M3: > 25% lymphoblasts. Bone marrow MRD status is defined as positive with >= 0.1 detectable leukemia cells, and negative with < 0.1 detectable leukemia cells.
Day 29
Correlation of Minimal Residual Disease (MRD) Positive With Event Free Survival (EFS)
Tidsramme: 5 years
Bone marrow MRD status is defined as positive with >= 0.1 detectable leukemia cells.
5 years
Correlation of Minimal Residual Disease (MRD) Negative With Event Free Survival (EFS).
Tidsramme: 5 years
Bone marrow MRD status is defined as negative with < 0.1 detectable leukemia cells.
5 years

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Samarbeidspartnere

Etterforskere

  • Hovedetterforsker: Eric C Larsen, Children's Oncology Group

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

29. desember 2003

Primær fullføring (Faktiske)

31. desember 2010

Studiet fullført (Faktiske)

31. mars 2021

Datoer for studieregistrering

Først innsendt

9. januar 2004

Først innsendt som oppfylte QC-kriteriene

12. januar 2004

Først lagt ut (Anslag)

13. januar 2004

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

27. april 2021

Siste oppdatering sendt inn som oppfylte QC-kriteriene

2. april 2021

Sist bekreftet

1. april 2021

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • AALL0232 (Annen identifikator: CTEP)
  • U10CA098543 (U.S. NIH-stipend/kontrakt)
  • 11723 (DAIDS ES Registry Number)
  • NCI-2009-00301 (Registeridentifikator: CTRP (Clinical Trial Reporting Program))
  • COG-AALL0232
  • CDR0000349182

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere